Clinical prediction of Parkinson's disease: planning for the age of neuroprotection

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2010-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2009.174748PMID 20562452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK).

  2010cited by this paper
• Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

  2010cited by this paper
• Medical records documentation of constipation preceding Parkinson disease: A case-control study

  2010cited by this paper
• Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease

  2009cited by this paper
• Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

  2009cited by this paper
• The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version.

  2009cited by this paper
• The neuropathological basis for depression in Parkinson's disease.

  2009cited by this paper
• Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.

  2009cited by this paper
• Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study

  2009cited by this paper
• Medical records documentation of constipation preceding Parkinson disease

  2009influential reference
• Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder

  2009cited by this paper
• TRANSCRANIAL SONOGRAPHY IN MOVEMENT DISORDERS

  2009cited by this paper
• Patterns and stages of α-synucleinopathy

  2008cited by this paper
• Association of olfactory dysfunction with risk for future Parkinson's disease

  2008influential reference
• REM SLEEP BEHAVIOR DISORDER PREDICTS COGNITIVE IMPAIRMENT IN PARKINSON DISEASE WITHOUT DEMENTIA

  2008cited by this paper
• Invited Article: Functional imaging in Parkinson disease

  2008cited by this paper
• Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder

  2008cited by this paper
• The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease

  2008cited by this paper
• REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features

  2008cited by this paper
• CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

  2008cited by this paper
• Invited Article: Nervous system pathology in sporadic Parkinson disease

  2008cited by this paper
• Transcranial sonography in movement disorders.

  2008cited by this paper
• Manifestations of Parkinson disease differ in association with REM sleep behavior disorder

  2008cited by this paper
• Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease

  2008cited by this paper
• The progression of pathology in longitudinally followed patients with Parkinson’s disease

  2008cited by this paper
• Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

  2008cited by this paper
• The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

  2008influential reference
• The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging

  2008cited by this paper
• Cardiac autonomic regulation during sleep in idiopathic REM sleep behavior disorder.

  2007cited by this paper
• Relation between subtype of Parkinson's disease and REM sleep behavior disorder.

  2007cited by this paper
• Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease

  2007cited by this paper
• Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons

  2007cited by this paper
• Olfactory loss may be a first sign of idiopathic Parkinson's disease

  2007cited by this paper
• Predictive testing for Huntington's disease.

  2007cited by this paper
• The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument

  2007cited by this paper
• Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease

  2007cited by this paper
• Positron emission tomography in premotor Parkinson's disease.

  2007cited by this paper
• Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

  2007cited by this paper
• Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.

  2007cited by this paper
• REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia

  2007cited by this paper
• Assessing whole brain perfusion changes in patients with REM sleep behavior disorder

  2006cited by this paper
• Olfaction in neurodegenerative disorder.

  2006cited by this paper
• Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.

  2006influential reference
• Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.

  2006cited by this paper
• Non-motor symptoms of Parkinson's disease: diagnosis and management.

  2006cited by this paper
• Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.

  2006cited by this paper
• What is the evidence for a premorbid parkinsonian personality: A systematic review

  2006cited by this paper
• Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder

  2006influential reference
• A systematic review of depression and mental illness preceding Parkinson's disease

  2006influential reference
• Depression in Parkinson's disease – a review

  2006cited by this paper
• Epidemiology of Parkinson's disease.

  2006influential reference
• Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder

  2006influential reference
• Depression in Parkinson's disease – a review

  2006cited by this paper
• Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.

  2005cited by this paper
• The role of radiotracer imaging in Parkinson disease.

  2005cited by this paper
• Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease

  2005cited by this paper
• Excessive daytime sleepiness and subsequent development of Parkinson disease

  2005cited by this paper
• Idiopathic REM sleep behavior disorder

  2005cited by this paper
• The role of radiotracer imaging in Parkinson disease.

  2005cited by this paper
• Smell identification ability in twin pairs discordant for Parkinson's disease

  2005cited by this paper
• Anosmia is very common in the Lewy body variant of Alzheimer’s disease

  2005cited by this paper
• Idiopathic hyposmia as a preclinical sign of Parkinson's disease

  2004cited by this paper
• Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

  2004cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003influential reference
• Olfaction in neurodegenerative disorder

  2003cited by this paper
• Slowing of electroencephalogram in rapid eye movement sleep behavior disorder

  2003cited by this paper
• Progress of visual dysfunction in Parkinson's disease

  2002cited by this paper
• Growth Hormone Therapy in the Glucocorticosteroid-Dependent Child: Metabolic and Linear Growth Effects

  2002cited by this paper
• REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease

  2002cited by this paper
• Relationship of substantia nigra echogenicity and motor function in elderly subjects

  2001cited by this paper
• Frequency of bowel movements and the future risk of Parkinson’s disease

  2001cited by this paper
• Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

  2001cited by this paper
• Functional Imaging in Parkinson's Disease

  2001cited by this paper
• Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery

  2000cited by this paper
• Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

  1999cited by this paper
• Parkinson disease in twins: an etiologic study.

  1999influential reference
• Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET

  1998cited by this paper
• 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold.

  1997cited by this paper
• Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.

  1997cited by this paper
• Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder.

  1996cited by this paper
• Prevalence of parkinsonian signs and associated mortality in a community population of older people.

  1996cited by this paper
• Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder

  1996cited by this paper
• Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

  1994cited by this paper
• Abnormalities in color vision and contrast sensitivity in Parkinson's disease

  1992cited by this paper
• Predictive testing for Huntington's Disease

  1988cited by this paper
• Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

  1984cited by this paper

• Educational Resources to Support Patients with Parasomnias.

  2024cites this paper
• Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severity

  2024cites this paper
• Optimization of Parkinson's disease therapy with plant extracts and nutrition’s evolving roles

  2024cites this paper
• The activities of daily living partially mediate the relationship between rapid eye movement sleep behavior disorder and depressive symptoms in Parkinson's disease

  2024cites this paper
• Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank

  2023cites this paper
• Prevalence and nature of self-reported visual complaints in people with Parkinson’s disease—Outcome of the Screening Visual Complaints questionnaire

  2023cites this paper
• The Therapeutic Potential of Salidroside for Parkinsonʼs Disease

  2022cites this paper
• A Supervised Machine Learning Approach to Classify Perkinson’s Disease

  2022cites this paper
• Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study

  2022cites this paper
• NDT_A_374370 1593..1601

  2022cites this paper
• Depression in Parkinson's Disease: A Narrative Review

  2022cites this paper
• Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases

  2022cites this paper
• Antibiotic Consumption Patterns in European Countries Are Associated with the Prevalence of Parkinson’s Disease; the Possible Augmenting Role of the Narrow-Spectrum Penicillin

  2022cites this paper
• The bile acid TUDCA and neurodegenerative disorders: An overview.

  2021cites this paper
• Biomarkers and the Role of α-Synuclein in Parkinson’s Disease

  2021cites this paper
• Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease

  2021cites this paper
• Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease

  2020cites this paper
• 123I-Ioflupane dopamine transporter imaging (DaTSCAN) appearances in relation to emotional responsiveness, impulsivity and olfaction in suspected Parkinsonian syndrome

  2020cites this paper
• Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s disease

  2020cites this paper
• Exercise and Parkinson's Disease.

  2020cites this paper
• Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder

  2019cites this paper
• Author Correction: A Human Neuroimaging Perspective on Sleep in Normative and Pathological Ageing

  2019cites this paper
• Exercise as a therapeutic intervention for motor and non-motor symptoms in Parkinson's disease: Evidence from rodent models.

  2019cites this paper
• Animal models of olfactory dysfunction in neurodegenerative diseases.

  2019cites this paper
• A Human Neuroimaging Perspective on Sleep in Normative and Pathological Ageing

  2019cites this paper
• A NEW PROCEDURE TO ISOLATE BRAIN MITOCHONDRIA FROM HUMAN CORTEX AND ITS APPLICATION FOR LIPID ANALYSIS IN PHYSIOLOGICAL AGING

  2018cites this paper
• The Causative and Curative Roles of Brain-Derived Neurotrophic Factor in Parkinson’s Disease

  2018cites this paper
• Neurodegenerative Disease Conditions and Genomic Treatment for Better Health

  2018cites this paper
• Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion

  2018cites this paper
• Neurodegenerative Chemosensory Disorders

  2018cites this paper
• Improving the management of Parkinson's disease : the experience of hospitalisation and a novel MRI-based diagnostic tool

  2017cites this paper
• Structural Brain Sex Differences in ParkinsonâÂÂs Disease: A Voxel-Based Morphometry Study

  2017cites this paper
• Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.

  2017cites this paper
• A predictive model to identify Parkinson disease from administrative claims data

  2017cites this paper
• The BSSG rat model of Parkinson’s disease: progressing towards a valid, predictive model of disease

  2017cites this paper
• Deregulation of &agr;‐synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA

  2017cites this paper
• Metacognitive knowledge of olfactory dysfunction in Parkinson's disease.

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development

  2016influential citation
• Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease

  2016cites this paper
• Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

  2016cites this paper
• DISRUPTION OF SLEEP AND CIRCADIAN RHYTHM ORGANIZATION AS RISK FACTORS FOR DIAGNOSIS OF ALZHEIMER’S DISEASE

  2016cites this paper
• Die Archimedesspirale - ein potentielles Werkzeug in der Früherkennung neurodegenerativer Erkrankungen? Testung von Tremores in der TREND-Studie

  2016influential citation
• Serum Autoantibodies as Biomarkers for Parkinsons Disease: Background and Utility

  2015cites this paper
• Expression of Parkinson's disease and associated neurophenotypes in 22q11.2 deletion syndrome

  2015influential citation
• Reasons for mild parkinsonian signs - which constellation may indicate neurodegeneration?

  2015cites this paper
• Characterization of early and mature electrophysiological biomarkers of patients with Parkinson’s disease

  2015influential citation
• Investigating the night-to-night variability of REM without atonia in Parkinson's disease.

  2015cites this paper
• Rational drug discovery design approaches for treating Parkinson’s disease

  2015cites this paper
• Prodromal features for Parkinson's disease – baseline data from the TREND study

  2014cites this paper
• Postural sway in idiopathic rapid eye movement sleep behavior disorder: a potential marker of prodromal Parkinson's disease.

  2014cites this paper
• The use of melatonin for treating sleep disorders in patients with Parkinson's disease

  2014cites this paper
• Improving the electrophysiological measurement of REM without atonia in the diagnosis of REM sleep behaviour disorder

  2014cites this paper
• Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease.

  2014cites this paper
• Functional imaging in pre-motor Parkinson's disease.

  2014cites this paper
• A novel treatment target for Parkinson's disease.

  2014cites this paper
• Nonmotor Symptoms in a Malaysian Parkinson's Disease Population

  2014cites this paper
• Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire

  2014cites this paper
• Data-driven modeling of sleep EEG and EOG reveals characteristics indicative of pre-Parkinson's and Parkinson's disease.

  2014cites this paper
• Mild Parkinsonian Signs in the Elderly – Is There an Association with PD? Crossectional Findings in 992 Individuals

  2014cites this paper
• Characterizing Spoken Discourse in Individuals with Parkinson Disease Without Dementia

  2014cites this paper
• The use of melatonin for treating sleep disorders in patients with Parkinson’s disease

  2014cites this paper
• Rotenone as Preclinical Model Compound in Parkinson Disease

  2014cites this paper
• Biomarkers in Parkinson's disease (recent update).

  2013cites this paper
• Sleep disorders in Parkinson’s disease: a narrative review of the literature

  2013cites this paper
• Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years.

  2013cites this paper
• Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16 year update on a previously reported series

  2013cites this paper
• Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?

  2013cites this paper
• Can population genomics guide future therapeutic gene transfer strategies for Parkinson’s disease?

  2013cites this paper
• The PRIPS study: screening battery for subjects at risk for Parkinson's disease

  2013cites this paper
• REM sleep behavior disorder in Parkinson's disease--is there a gender difference?

  2013cites this paper
• A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

  2013cites this paper
• Skin and wound issues in patients with Parkinson's disease: an overview of common disorders.

  2013cites this paper
• Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.

  2013cites this paper
• REM sleep behaviour disorder: a marker of synucleinopathy.

  2013cites this paper
• Prodromale Marker der Parkinson-Krankheit

  2013cites this paper
• Redefining Parkinson’s disease

  2013cites this paper
• Overview of Parkinson's Disease: Examing the role for the Gut-Brain-Gut axis and the use of Nutrients based on preclinical and clinical evidence

  2013cites this paper
• Predicting neurodegenerative disease in idiopathic rapid eye movement (REM) sleep behavior disorder: Conference proceedings, REM Sleep Behavior Symposium 2011

  2013cites this paper
• REM sleep behaviour disorder: a marker of synucleinopathy

  2013cites this paper
• Étude de la perfusion cérébrale régionale dans le trouble comportemental en sommeil paradoxal

  2013cites this paper
• Development of the Huntington Disease Work Function Scale

  2012cites this paper
• Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease

  2012cites this paper
• How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.

  2012cites this paper
• Overview of Parkinson’s Disease: Examining the Role for the Gut-Brain- Gut Axis and the Use of Nutrients Based on Preclinical and Clinical Evidence

  2012cites this paper
• Sleep, Adenosine and Caffeine as Tools for The Early Diagnosis of Parkinson Disease

  2012cites this paper
• Attenuated heart rate response in REM sleep behavior disorder and Parkinson's disease

  2012cites this paper
• Validation of the non-motor symptoms questionnaire (NMS-Quest).

  2012cites this paper
• Is pre-motor diagnosis possible? The European experience.

  2012cites this paper
• Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease

  2012influential citation
• Impaired Trunk Stability in Individuals at High Risk for Parkinson's Disease

  2012cites this paper
• Motor signs in the prodromal phase of Parkinson's disease

  2012cites this paper
• The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.

  2012cites this paper
• Biopsychosocial and Spiritual Aspects of Parkinson Disease: An Integrative Review

  2012cites this paper
• REM sleep behavior disorder: from dreams to neurodegeneration.

  2012cites this paper
• Basal ganglia sonography: Will it mature into a preclinical diagnostic tool for Parkinson’s disease?

  2012cites this paper
• Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease

  2012cites this paper
• Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.

  2012cites this paper
• Defining at‐risk populations for Parkinson's disease: Lessons from ongoing studies

  2012cites this paper
• Parkinson’s disease and affective disorder: The temporal relationship

  2012cites this paper